BIOV-111 a European phase II trial of clofarabine (Evoltra® in refractory and relapsed childhood acute lymphoblastic leukemia.

被引：7
|
作者：
Kearns, Pamela
Michel, Gerard
Nelken, Brigitte
Joel, Simon
Al-Ghazaly, Essam
Beishuizen, Auke
Conter, Valentino
Gadner, Helmut
Henze, Gunter
Smith, Hazel
Baruchel, Andre
Saha, Vaskar
机构：
[1] Univ Bristol, Bristol, Avon, England
[2] Hosp Timone, Marseille, France
[3] Hosp Jeanne Flandre, Lille, France
[4] St Bartholomews Hosp, Canc Pharmacol Grp, London, England
[5] Erasmus MC Sophia Childrens Hosp, Rotterdam, Netherlands
[6] Osped Nuovo San Gerardo, Monza, Italy
[7] Univ Vienna, St Anna Kinderspital, Vienna, Austria
[8] Charite Univ Med Berlin, Berlin, Germany
[9] Bioenvision Ltd, Edinburgh, Midlothian, Scotland
[10] Hosp St Louis, Paris, France
[11] Univ Manchester, CRUK, Childrens Canc Grp, Manchester, Lancs, England
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.1859.1859
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1859
引用
收藏
页码：527A / 527A
页数：1
相关论文
共 50 条
  • [1] A European phase II study (BIOV-111) of clofarabine (Evoltra®) in refractory and relapsed childhood acute lymphoblastic leukemia:: Final results
    Kearns, Pamela
    Michel, Gerard
    Nelken, Brigitte
    Joel, Simon
    Al-Ghazaly, Essam
    Beishuizen, Auke
    Conter, Valentino
    Henze, Gunter
    Baruchel, Andre
    Saha, Vaskar
    BLOOD, 2007, 110 (11) : 11A - 11A
  • [2] Phase II trials of clofarabine in relapsed or refractory pediatric leukemia.
    Jeha, S
    Razzouk, BI
    Ryttin, ME
    Gaynon, PS
    Kadota, R
    Rheingold, S
    Luchtman-Jones, L
    Shen, V
    Arceci, RJ
    Fernandez, M
    Weitman, S
    Steinherz, PG
    BLOOD, 2004, 104 (11) : 196A - 197A
  • [3] A phase II, open-label study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
    Jeha, S
    Gaynon, P
    Steinherz, P
    Kadota, R
    Bomgaars, L
    Razzouk, B
    Luchtman-Jones, L
    Altman, A
    Rheingold, S
    Ritchey, AK
    Shen, V
    Weiss, J
    Chan, KW
    Craig, A
    Arceci, RJ
    BLOOD, 2003, 102 (11) : 881A - 881A
  • [4] Phase II results of mitoxantrone in combination with clofarabine in children with relapsed/refractory acute leukemia.
    Hochberg, Jessica
    Oesterheld, Javier E.
    Flower, Allyson
    Klejmont, Liana
    Basso, Jaclyn
    Harrison, Lauren
    Shi, Qiuhu
    Borowitz, Michael J.
    Loken, Michael
    Cairo, Mitchell S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
    Jeha, S
    Gaynon, PS
    Razzouk, BI
    Franklin, J
    Kadota, R
    Shen, V
    Litchtman-Jones, L
    Rytting, M
    Bomgaars, LR
    Rheingold, S
    Ritchey, K
    Albano, E
    Arceci, RJ
    Goldman, S
    Griffin, T
    Altman, A
    Gordon, B
    Steinherz, L
    Weitman, S
    Steinherz, P
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1917 - 1923
  • [6] PHASE I/II TRIAL OF MITOXANTRONE AND CLOFARABINE IN CHILDREN WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA
    Hochberg, Jessica
    Oesterheld, Javier
    Gardenswartz, Aliza
    Klejmont, Liana
    Harrison, Lauren
    Basso, Jaclyn
    Borowitz, Michael
    Loken, Michael
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [7] Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol
    Bassan, Renato
    Fumagalli, Monica
    Chiaretti, Sabina
    Audisio, Ernesta
    Cascayilla, Nicola
    Paolini, Stefania
    Delia, Mario
    Cerqui, Elisa
    Mico, Caterina
    Fabbiano, Francesco
    Canichella, Martina
    Scattolin, Anna Maria
    Perfetti, Paola
    Paoloni, Francesca
    Iodice, Mariangela
    Vitale, Antonella
    Della Starza, Irene
    Fazi, Paola
    Vignetti, Marco
    Foa, Robin
    LEUKEMIA & LYMPHOMA, 2019, 60 (14) : 3482 - 3492
  • [8] A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia
    Litzow, Mark R.
    Lee, Sandra
    Bennett, John M.
    Dewald, Gordon W.
    Gallagher, Robert E.
    Jain, Vibha
    Paietta, Elisabeth M.
    Racevskis, Janis
    Rousey, Steven R.
    Mazza, Joseph J.
    Tallman, Martin S.
    HAEMATOLOGICA, 2006, 91 (08) : 1105 - 1108
  • [9] The Role of Clofarabine in the Treatment of Relapsed Childhood Acute Lymphoblastic Leukemia
    Goto, Hiroaki
    Kada, Akiko
    Toyoda, Hidemi
    Ogawa, Chitose
    Horibe, Keizo
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [10] A phase II, open-label study of clofarabine in pediatric patients with refractory or relapsed acute myelogenous leukemia.
    Jeha, S
    Steinherz, P
    Gaynon, P
    Rheingold, S
    Razzouk, B
    Ritchey, AK
    Altman, A
    Albano, E
    Stine, K
    Chan, KW
    Weiss, J
    Craig, A
    Arceci, RJ
    BLOOD, 2003, 102 (11) : 617A - 617A
12345